Lilly acquires Dermira for $1.1bn, expands dermatology portfolio
Eli Lilly set to acquire dermatological drugs developer, Dermira, in an $1.1bn all-cash deal, adding commercial and late-stage drugs to its portfolio.
Archives for January 15, 2020
Astellas continues to make deals, partnering with Adaptimmune
The newly established deal includes the co-development of up to three T-cell therapies, by utilizing the latter’s stem-cell derived allogeneic T-cell platform.
Surging local demand drives 24% growth of Korean contract service sector
South Korean contract service market grows 24% as local biopharma companies step up spending.